AHFS Drug Information 2021 1st Edition
SKU:
NT$14,080.00
NT$14,080.00
無法使用
每件商品
Pre-order
- Publisher : American Society of Health-Systems Pharmacists; 1st edition (January 1, 2021)
- ISBN-13 : 978-1585286546
Product Details:
AHFS Drug Information® 2021 contains the most trustworthy drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.
Updates in the 2021 Edition include:
- Drug information for COVID-19-related treatments, including use of antiviral agents such as remdesivir and lopinavir/ritonavir, SARS-CoV-2-specific monoclonal antibodies (e.g., bamlanivimab), as well as use of supporting agents such as corticosteroids, immune globulin, nitric oxide, and tocilizumab
- Updated information on drugs commonly used for ICU sedation in critically ill patients with COVID-19, including propofol, dexmedetomidine, and midazolam and alternative drugs such as ketamine considered in potential drug shortage situations
- Latest oncology therapies for the treatment of cancers associated with activating gene mutations and oncogenic gene fusions
- Breakthroughs in oncology approved under the FDA's accelerated approval program
- New information on non-oncology off-label uses